Our study in Lancet Global Health highlights the global disparity between high income and low-income countries in terms of retinoblastoma survival and globe salvage rate, and identifies socioeconomic risk factors associated with both. This information will be useful to raise awareness among policy makers and nongovernmental organizations as well as to guide resource allocation for retinoblastoma treatment on both a local and international level.
